Identification of cathepsin L as a potential sex-specific biomarker for renal damage

Hypertension

Volumn 57, Issue 4, 2011, Pages 795-801

  Bauer, Yasmina ^a   Hess, Patrick ^a   Qiu, Changbin ^a   Klenk, Axel ^a   Renault, Bérengère ^a   Wanner, Daniel ^a   Studer, Rolf ^a   Killer, Nina ^a   Stalder, Anna Katharina ^a   Stritt, Manuel ^a   Strasser, Daniel Stefan ^a   Farine, Hervé ^a   Kauser, Katalin ^a   Clozel, Martine ^a   Fischli, Walter ^a   Nayler, Oliver ^a  

^a ACTELION PHARMACEUTICALS LTD   (Switzerland)

Author keywords

double transgenic rats; gene expression; hypertension; oxidative stress; renal disease; renin angiotensin system; sex difference

Indexed keywords

ALBUMIN; ARGINASE 1; BIOLOGICAL MARKER; CATHEPSIN L; CRYPTOCHROME 1; EXTRACELLULAR SUPEROXIDE DISMUTASE; KIDNEY INJURY MOLECULE 1; PROLACTIN RECEPTOR; PROTEIN; RNA; VASCULOTROPIN A;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENOME; GLOMERULUS FILTRATION RATE; IMMUNOASSAY; INTERSTITIAL NEPHRITIS; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY VASCULAR RESISTANCE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RAT; RENOVASCULAR DISEASE; SEX DIFFERENCE; URINE FLOW RATE;

ANALYSIS OF VARIANCE; ANGIOTENSINOGEN; ANIMALS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CATHEPSIN L; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; RENAL CIRCULATION; RENIN; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX CHARACTERISTICS; TISSUE ARRAY ANALYSIS; VASCULAR RESISTANCE;

EID: 79953213344     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.157206     Document Type: Article

References (46)

1. United Nations, Department of International Economic and Social Affairs, Population Division. Sex differentials in life expectancy and mortality in developed countries: an analysis by age groups and causes of death from recent and historical data. Popul Bull UN. 1988;25:65-107.
2. Wiinberg N, Hoegholm A, Christensen HR, Bang LE, Mikkelsen KL, Nielsen PE, Svendsen TL, Kampmann JP, Madsen NH, Bentzon MW. 24-H ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens. 1995;8:978-986.
3. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C, Roccella EJ. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult us population: data from the health examination surveys, 1960 to 1991. Hypertension. 1995;26:60-69.
4. US Renal Data System. USRDS 2005 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: US Renal Data System; 2006.
5. Rosman JB, Langer K, Brandl M, Piers-Becht TP, van der Hem GK, ter Wee PM, Donker AJ. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney Int Suppl. 1989; 27:S96-S102. (Pubitemid 19285083)
6. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 2000; 11:319-329. (Pubitemid 30064855)
7. Kang AK, Miller JA. Impact of gender on renal disease: the role of the renin angiotensin system. Clin Invest Med. 2003;26:38-44. (Pubitemid 36629705)
8. Sandberg K, Ji H. Sex and the renin angiotensin system: Implications for gender differences in the progression of kidney disease. Adv Ren Replace Ther. 2003;10:15-23. (Pubitemid 36278326)
9. Verhagen AM, Attia DM, Koomans HA, Joles JA. Male gender increases sensitivity to proteinuria induced by mild NOS inhibition in rats: Role of sex hormones. Am J Physiol Renal Physiol. 2000;279:F664-F670.
10. Reckelhoff JF, Zhang H, Srivastava K. Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system. Hypertension. 2000;35:480-483. (Pubitemid 30054220)
11. Crofton JT, Share L. Gonadal hormones modulate deoxycorticosterone-salt hypertension in male and female rats. Hypertension. 1997;29:494-499. (Pubitemid 27074089)
12. Crofton JT, Ota M, Share L. Role of vasopressin, the renin-angiotensin system and sex in Dahl salt-sensitive hypertension. J Hypertens. 1993; 11:1031-1038. (Pubitemid 23307874)
13. Okuniewski R, Davis EA, Jarrott B, Widdop RE. A comparison of the development of renal hypertension in male and female rats. Clin Sci (Lond). 1998;95:445-451. (Pubitemid 28474730)
14. Bohlender J, Fukamizu A, Lippoldt A, Nomura T, Dietz R, Menard J, Murakami K, Luft FC, Ganten D. High human renin hypertension in transgenic rats. Hypertension. 1997;29:428-434. (Pubitemid 27074079)
15. Mervaala E, Dehmel B, Gross V, Lippoldt A, Bohlender J, Milia AF, Ganten D, Luft FC. Angiotensin-converting enzyme inhibition and AT1 receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with human renin and angiotensinogen genes. J Am Soc Nephrol. 1999;10:1669-1680. (Pubitemid 29364665)
16. Luft FC, Mervaala E, Muller DN, Gross V, Schmidt F, Park JK, Schmitz C, Lippoldt A, Breu V, Dechend R, Dragun D, Schneider W, Ganten D, Haller H. Hypertension-induced end-organ damage: a new transgenic approach to an old problem. Hypertension. 1999;33:212-218. (Pubitemid 29065662)
17. Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, Theuer J, Breu V, Ganten D, Haller H, Luft FC. NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension. 2000;35:193-201. (Pubitemid 30054172)
18. Roux S, Qiu C, Sprecher U, Osterwalder R, Clozel JP. Protective effects of endothelin receptor antagonists in dogs with aortic cross-clamping. J Cardiovasc Pharmacol. 1999;34:199-205. (Pubitemid 29350500)
19. Clozel M, Binkert C, Birker-Robaczewska M, Boukhadra C, Ding SS, Fischli W, Hess P, Mathys B, Morrison K, Muller C, Muller C, Nayler O, Qiu C, Rey M, Scherz MW, Velker J, Weller T, Xi JF, Ziltener P. Pharmacology of the urotensin-II receptor antagonist palosuran (Act-058362; 1-[2-(4-benzyl-4- hydroxy-piperidin-1-yl)-ethyl]-3-(2-methylquinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin system. J Pharmacol Exp Ther. 2004;311: 204-212. (Pubitemid 39302621)
20. Baylis C, Harton P, Engels K. Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol. 1990; 1:875-881.
21. Qiu C, Engels K, Baylis C. Angiotensin II and-1-adrenergic tone in chronic nitric oxide blockade-induced hypertension. Am J Physiol. 1994; 266:R1470-R1476.
22. Qiu C, Engels K, Baylis C. Endothelin modulates the pressor actions of acute systemic nitric oxide blockade. J Am Soc Nephrol. 1995;6: 1476-1481.
23. Ding SS, Qiu C, Hess P, Xi JF, Clozel JP, Clozel M. Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure. Cardiovasc Res. 2002;53:963-970. (Pubitemid 34261034)
24. Ding SS, Qiu C, Hess P, Xi JF, Zheng N, Clozel M. Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the rat. J Cardiovasc Pharmacol. 2003;42:48-54. (Pubitemid 36791349)
25. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics. 2002;18(suppl 1):S96-S104. (Pubitemid 41185642)
26. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article3.
27. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B. 1995;57:289-300.
28. Birker-Robaczewska M, Boukhadra C, Studer R, Mueller C, Binkert C, Nayler O. The expression of urotensin II receptor (u2r) is up-regulated by interferon-. J Recept Signal Transduct Res. 2003;23:289-305. (Pubitemid 38018398)
29. Theuer J, Dechend R, Muller DN, Park JK, Fiebeler A, Barta P, Ganten D, Haller H, Dietz R, Luft FC. Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats. BMC Cardiovasc Disord. 2002;2:3.
30. Olbricht CJ, Cannon JK, Garg LC, Tisher CC. Activities of cathepsins B and L in isolated nephron segments from proteinuric and nonproteinuric rats. Am J Physiol. 1986;250:F1055-F1062.
31. Eisenberger U, Fels LM, Olbricht CJ, Stolte H. Cathepsin B and L in isolated proximal tubular segments during acute and chronic proteinuria. Ren Physiol Biochem. 1995;18:89-96.
32. Mervaala E, Muller DN, Schmidt F, Park JK, Gross V, Bader M, Breu V, Ganten D, Haller H, Luft FC. Blood pressure-independent effects in rats with human renin and angiotensinogen genes. Hypertension. 2000;35: 587-594. (Pubitemid 30108153)
33. Mervaala EM, Muller DN, Park JK, Schmidt F, Lohn M, Breu V, Dragun D, Ganten D, Haller H, Luft FC. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension. 1999;33:389-395. (Pubitemid 29065690)
34. Dehmel B, Mervaala E, Lippoldt A, Gross V, Bohlender J, Ganten D, Luft FC. Pressure-natriuresis and-diuresis in transgenic rats harboring both human renin and human angiotensinogen genes. J Am Soc Nephrol. 1998;9:2212-2222. (Pubitemid 28543799)
35. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992;19:464-474.
36. Gerhold D, Bagchi A, Lu M, Figueroa D, Keenan K, Holder D, Wang Y, Jin H, Connolly B, Austin C, Alonso-Galicia M. Androgens drive divergent responses to salt stress in male versus female rat kidneys. Genomics. 2007;89:731-744. (Pubitemid 46719794)
37. Sullivan JC, Sasser JM, Pollock JS. Sexual dimorphism in oxidant status in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2007;292:R764-R768. (Pubitemid 46207728)
38. Ji H, Pesce C, Zheng W, Kim J, Zhang Y, Menini S, Haywood JR, Sandberg K. Sex differences in renal injury and nitric oxide production in renal wrap hypertension. Am J Physiol Heart Circ Physiol. 2005;288: H43-H47. (Pubitemid 40023826)
39. Ji H, Zheng W, Menini S, Pesce C, Kim J, Wu X, Mulroney SE, Sandberg K. Female protection in progressive renal disease is associated with estradiol attenuation of superoxide production. Gend Med. 2007;4:56-71. (Pubitemid 46917068)
40. Gossrau R. Peptide and protein handling by proteases in the kidney of laboratory rodents. Acta Histochem Suppl. 1983;28:285-293.
41. Puente XS, Lopez-Otin C. A genomic analysis of rat proteases and protease inhibitors. Genome Res. 2004;14:609-622. (Pubitemid 38500232)
42. Jedrzejewski K, Kugler P. Peptidases in the kidney and urine of rats after castration. Histochemistry. 1982;74:63-84. (Pubitemid 12058357)
43. Sever S, Altintas MM, Nankoe SR, Moller CC, Ko D, Wei C, Henderson J, del Re EC, Hsing L, Erickson A, Cohen CD, Kretzler M, Kerjaschki D, Rudensky A, Nikolic B, Reiser J. Proteolytic processing of dynamin by cytoplasmic cathepsin l is a mechanism for proteinuric kidney disease. J Clin Invest. 2007;117:2095-2104. (Pubitemid 47219554)
44. European Medicines Agency. Final report on the pilot joint EMEA/FDA VXDS experience on qualification of nephrotoxicity biomarkers. London, United Kingdom: European Medicines Agency; 2008.
45. Vaidya VS, Ozer JS, Dieterle F, Collings FB, Ramirez V, Troth S, Muniappa N, Thudium D, Gerhold D, Holder DJ, Bobadilla NA, Marrer E, Perentes E, Cordier A, Vonderscher J, Maurer G, Goering PL, Sistare FD, Bonventre JV. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol. 28:478-485.
46. Furuyama N, Fujisawa Y. Regulation of collagenolytic cysteine protease synthesis by estrogen in osteoclasts. Steroids. 2000;65:371-378. (Pubitemid 30427334)